日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San Francisco

在旧金山开展的一项试点研究:实施 Xpert HIV-1 病毒载量即时检测的可行性及员工接受度

Moore, Kelvin Jr; Tourneau, Noelle Le; Alvarez, Jasmin; Rodriguez, Santos; Broussard, Janessa; Crouch, Pierre-Cédric; Roman, Jorge; Defechereux, Patricia; Bena, Jason; Koester, Kimberly A; Moran, Lissa; Pilcher, Christopher; Grant, Robert; Christopoulos, Katerina A

Suppressed HIV antibody responses following exposure to antiretrovirals-evidence from PrEP randomized trials and early antiretroviral treatment initiation studies

暴露于抗逆转录病毒药物后HIV抗体反应受到抑制——来自暴露前预防随机试验和早期抗逆转录病毒治疗启动研究的证据

Avelino-Silva, Vivian I; Stone, Mars; Bakkour, Sonia; Di Germanio, Clara; Schmidt, Michael; Conway, Ashtyn L; Wright, David; Grebe, Eduard; Custer, Brian; Kleinman, Steven H; Deng, Xutao; Lingappa, Jairam R; Defechereux, Patricia; Mehrotra, Megha; Grant, Robert M; Vasan, Sandhya; Facente, Shelley; Phanuphak, Nittaya; Sacdalan, Carlo; Akapirat, Siriwat; de Souza, Mark; Busch, Michael P; Norris, Philip J

HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing

HIV-1 缓解:加速实现 HIV-1 永久沉默之路

Lyons, Danielle E; Kumar, Priti; Roan, Nadia R; Defechereux, Patricia A; Feschotte, Cedric; Lange, Ulrike C; Murthy, Niren; Sameshima, Pauline; Verdin, Eric; Ake, Julie A; Parsons, Matthew S; Nath, Avindra; Gianella, Sara; Smith, Davey M; Kallas, Esper G; Villa, Thomas J; Strange, Richard; Mwesigwa, Betty; Furler O'Brien, Robert L; Nixon, Douglas F; Ndhlovu, Lishomwa C; Valente, Susana T; Ott, Melanie

Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis

利用药物水平检测和单基因组测序揭示暴露前预防期间人类免疫缺陷病毒血清转化的病例

Spinelli, Matthew A; Lowery, Brentton; Shuford, Jennifer A; Spindler, Jon; Kearney, Mary F; McFarlane, Jenny R; McDonald, Cheryl; Okochi, Hideaki; Phung, Nhi; Kuncze, Karen; Jee, Kathryn; Johannessen, DeeJay; Anderson, Peter L; Smith, Dawn K; Defechereux, Patricia; Grant, Robert M; Gandhi, Monica

Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study

性激素疗法与干血斑中替诺福韦二磷酸盐浓度:抗逆转录病毒药物与跨性别激素相互作用研究的主要结果

Grant, Robert M; Pellegrini, Marion; Defechereux, Patricia A; Anderson, Peter L; Yu, Michelle; Glidden, David V; O'Neal, Joshua; Yager, Jenna; Bhasin, Shalender; Sevelius, Jae; Deutsch, Madeline B

HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health

使用富马酸替诺福韦酯/恩曲他滨进行HIV暴露前预防以及肾功能和肾小管健康的变化

Ascher, Simon B; Scherzer, Rebecca; Estrella, Michelle M; Shigenaga, Judy; Spaulding, Kimberly A; Glidden, David V; Mehrotra, Megha L; Defechereux, Patricia; Gandhi, Monica; Grant, Robert M; Shlipak, Michael G; Jotwani, Vasantha

Brief Report: High Accuracy of a Real-Time Urine Antibody-Based Tenofovir Point-of-Care Test Compared With Laboratory-Based ELISA in Diverse Populations

简报:实时尿液抗体检测法与实验室ELISA法在不同人群中具有较高的替诺福韦即时检测准确率

Spinelli, Matthew A; Rodrigues, Warren C; Wang, Guohong; Vincent, Michael; Glidden, David V; Okochi, Hideaki; Stalter, Randy; Defechereux, Patricia; Deutsch, Madeline; Grant, Robert M; Ngure, Kenneth; Mugo, Nelly R; Baeten, Jared M; Gandhi, Monica

Identification of hepatitis B virus genotype I in Thailand

泰国乙型肝炎病毒I型基因型的鉴定

Holzmayer, Vera; Hance, Robert; Defechereux, Patricia; Grant, Robert; Kuhns, Mary C; Cloherty, Gavin; Rodgers, Mary A

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project

大型暴露前预防(PrEP)示范项目中,估计的暴露前预防(PrEP)依从性模式对骨矿物质密度的影响

Spinelli, Matthew A; Glidden, David V; Anderson, Peter L; Gandhi, Monica; McMahan, Vanessa M; Defechereux, Patricia; Schechter, Mauro; Veloso, Valdiléa G; Chariyalertsak, Suwat; Guanira, Juan V; Bekker, Linda-Gail; Buchbinder, Susan P; Grant, Robert M

Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States

拓展艾滋病预防方案选择:一项关于美国二期临床试验中长效注射卡博特韦作为暴露前预防药物的经验的定性研究

Kerrigan, D; Mantsios, A; Grant, R; Markowitz, M; Defechereux, P; La Mar, M; Beckham, S W; Hammond, P; Margolis, D; Murray, M